The levels of several smooth muscle cell-associated proteins decreased in AD ACA relative to controls, specifically perlecan, myosin light polypeptide 6 and myosin regulatory light polypeptide 9, and leiomodin-1 (FDR < 0.05) (Fig. 7). Here, LMOD1 is linked to Alzheimer disease.